Pediatric Plaque Psoriasis Treatment Set to Expand in Europe

by | Apr 27, 2026 | Health

Spread the love
European regulators have recommended expanding use of the IL-23 inhibitor Skyrizi to treat moderate-to-severe plaque psoriasis in children aged 6 years or older who require systemic therapy.
Medscape News Europe

Written By

Written by Albert Pham, News Curator and Blogger

Related Posts

0 Comments